Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Karin Fröse"'
Autor:
Sven Diederichs, Lorenz Bartsch, Julia C Berkmann, Karin Fröse, Jana Heitmann, Caroline Hoppe, Deetje Iggena, Danny Jazmati, Philipp Karschnia, Miriam Linsenmeier, Thomas Maulhardt, Lino Möhrmann, Johannes Morstein, Stella V Paffenholz, Paula Röpenack, Timo Rückert, Ludger Sandig, Maximilian Schell, Anna Steinmann, Gjendine Voss, Jacqueline Wasmuth, Maria E Weinberger, Ramona Wullenkord
Publikováno v:
EMBO Molecular Medicine, Vol 8, Iss 5, Pp 442-457 (2016)
Abstract Cancer is a disease of the genome caused by oncogene activation and tumor suppressor gene inhibition. Deep sequencing studies including large consortia such as TCGA and ICGC identified numerous tumor‐specific mutations not only in protein
Externí odkaz:
https://doaj.org/article/f493a237e7b24fe5b81baf1eb7e2e60f
Autor:
Karin Fröse, Miriam Linsenmeier, Julia C. Berkmann, Jana Heitmann, Lino Möhrmann, Gjendine Voss, Philipp Karschnia, Sven Diederichs, Deetje Iggena, Caroline Hoppe, Lorenz Bartsch, Maria E Weinberger, Paula Röpenack, Johannes Morstein, Timo Rückert, Anna Steinmann, Stella V Paffenholz, Ludger Sandig, Ramona Wullenkord, Jacqueline Wasmuth, Danny Jazmati, Maximilian Schell, Thomas Maulhardt
Publikováno v:
Diederichs, S, Bartsch, L, Berkmann, J C, Fröse, K, Heitmann, J, Hoppe, C, Iggena, D, Jazmati, D, Karschnia, P, Linsenmeier, M, Maulhardt, T, Möhrmann, L, Morstein, J, Paffenholz, S V, Röpenack, P, Rückert, T, Sandig, L, Schell, M, Steinmann, A, Voss, G, Wasmuth, J, Weinberger, M E & Wullenkord, R 2016, ' The dark matter of the cancer genome: aberrations in regulatory elements, untranslated regions, splice sites, non-coding RNA and synonymous mutations ', EMBO Molecular Medicine, vol. 8, no. 5, pp. 442-57 . https://doi.org/10.15252/emmm.201506055
EMBO Molecular Medicine
EMBO Molecular Medicine
Cancer is a disease of the genome caused by oncogene activation and tumor suppressor gene inhibition. Deep sequencing studies including large consortia such as TCGA and ICGC identified numerous tumor‐specific mutations not only in protein‐coding